SPARQL
Downloads
Documentation/Help
Skip Header
Results
Your Query
Add common prefixes
DESCRIBE <http://purl.uniprot.org/SHA-384/8108F5FB9AE42B4EE2F75788079909278E3FF8DCD944CB8B83BEB90C22AF77D94A741C7B259D6D00B50C770CE0A8ACC4>
Submit Query
Cancel
RDF/XML
NTriples
Turtle
Show query
Share
Subject
Predicate
Object
http://purl.uniprot.org/SHA-384/8108F5FB9AE42B4EE2F75788079909278E3FF8DCD944CB8B83BEB90C22AF77D94A741C7B259D6D00B50C770CE0A8ACC4
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://purl.uniprot.org/core/Annotation
http://purl.uniprot.org/SHA-384/8108F5FB9AE42B4EE2F75788079909278E3FF8DCD944CB8B83BEB90C22AF77D94A741C7B259D6D00B50C770CE0A8ACC4
http://www.w3.org/2000/01/rdf-schema#comment
"Immunohistochemical results revealed that ALK was expressed in 16 of 142 (11.3%) of SCLCs. The expression was focal and less intense which is in contrast to strong and uniform expression in adenocarcinoma with ALK rearrangement."
xsd:string
http://purl.uniprot.org/uniprot/#_A1D987822ADF3C1ACF4A5AD23644922EB838969FFEADA119BE63579B531C3DBA755112903AA5011E1D88EA2AA126A0E3
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
http://purl.uniprot.org/SHA-384/8108F5FB9AE42B4EE2F75788079909278E3FF8DCD944CB8B83BEB90C22AF77D94A741C7B259D6D00B50C770CE0A8ACC4
http://purl.uniprot.org/uniprot/Q9UM73
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/8108F5FB9AE42B4EE2F75788079909278E3FF8DCD944CB8B83BEB90C22AF77D94A741C7B259D6D00B50C770CE0A8ACC4
http://purl.uniprot.org/uniprot/#_Q9UM73-mappedCitation-30790327
http://purl.uniprot.org/core/mappedAnnotation
http://purl.uniprot.org/SHA-384/8108F5FB9AE42B4EE2F75788079909278E3FF8DCD944CB8B83BEB90C22AF77D94A741C7B259D6D00B50C770CE0A8ACC4